Evidence map›Paper›PMID 34884703›Full record

ReviewInternational journal of molecular sciences2021

Effects of Intermittent Hypoxia on Cytokine Expression Involved in Insulin Resistance.

Tomoko Uchiyama, Hiroyo Ota, Chiho Ohbayashi, Shin Takasawa

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Identifying clusters of patient comorbidities associated with obstructive sleep apnea using electronic health records.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2024
    Article
  7. Review
  8. Article
  9. The Impact of Intermittent Hypoxia on Metabolism and Cognition.International journal of molecular sciences · 2022
    Review
  10. Article
  11. Editorial to Special Issue "Sleep Apnea and Intermittent Hypoxia 2.0".International journal of molecular sciences · 2022
    Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Tomoko UchiyamaDepartment of Biochemistry, Nara Medical University, Kashihara 634-8521, Japan.
Hiroyo OtaDepartment of Respiratory Medicine, Nara Medical University, Kashihara 634-8522, Japan.
Chiho OhbayashiDepartment of Diagnostic Pathology, Nara Medical University, Kashihara 634-8522, Japan.
Shin TakasawaDepartment of Biochemistry, Nara Medical University, Kashihara 634-8521, Japan.ORCID 0000-0002-4066-0199
Nara Medical University · JP

Funding

Kaken Pharmaceutical (Japan) 08102003, 15K19425, 18K15067 and 21K15389
6 · The paper itself

Abstract

Sleep apnea syndrome (SAS) is a prevalent disorder characterized by recurrent apnea or hypoxia episodes leading to intermittent hypoxia (IH) and arousals during sleep. Currently, the relationship between SAS and metabolic diseases is being actively analyzed, and SAS is considered to be an independent risk factor for the development and progression of insulin resistance/type 2 diabetes (T2DM). Accumulating evidence suggests that the short cycles of decreased oxygen saturation and rapid reoxygenation, a typical feature of SAS, contribute to the development of glucose intolerance and insulin resistance. In addition to IH, several pathological conditions may also contribute to insulin resistance, including sympathetic nervous system hyperactivity, oxidative stress, vascular endothelial dysfunction, and the activation of inflammatory cytokines. However, the detailed mechanism by which IH induces insulin resistance in SAS patients has not been fully revealed. We have previously reported that IH stress may exacerbate insulin resistance/T2DM, especially in hepatocytes, adipocytes, and skeletal muscle cells, by causing abnormal cytokine expression/secretion from each cell. Adipose tissues, skeletal muscle, and the liver are the main endocrine organs producing hepatokines, adipokines, and myokines, respectively. In this review, we focus on the effect of IH on hepatokine, adipokine, and myokine expression.

Indexed as

Insulin ResistanceAnimalsCytokinesGlucose IntoleranceHumansHypoxiaCytokinesadipokineshepatokinesinsulin resistanceintermittent hypoxiamyokinessleep apnea syndrome

Identifiers

PMID34884703
PMCPMC8657675
OpenAlexW3217004195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.